Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response

Blood

Volumn 89, Issue 3, 1997, Pages 910-918

  Ross, Mary E ^a   Caligiuri, Michael A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIAGNOSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; LEUKEMIA CELL LINE; NATURAL KILLER CELL; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE ACTIVATION;

EID: 0030981927     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.3.910     Document Type: Article

References (38)

1. Bancroft GJ, Schreiber RD, Unanue ER: Natural immunity: A T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev 124:5, 1991
2. Biron CA, Gazzinelli RT: Effects of IL-12 on immune responses to microbial infections: A key mediator in regulating disease outcome. Curr Opin Immunol 7:485, 1995
3. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G: Induction of interferon γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J Exp Med 173:869, 1991
4. Tripp CS, Wolf SF, Unanue ER: Interleukin 12 and tumor necrosis factor-α are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 90:3725, 1993
5. Gazzinelli RT, Hieny S, Wynn TA, Wolf SF, Sher A: Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 90:6115, 1993
6. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA: Interleukin 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395, 1994
7. Tsudo M, Goldman CK, Bongiovanni KF, Chan WC, Winton E, Yagita M, Grimm EA, Waldmann TA: The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc Natl Acad Sci USA 84:5394, 1987
8. Naume B, Gately MK, Desai BB, Sundan A, Espervik T: Synergistic effects of interleukin 4 and interleukin 12 on NK cell proliferation. Cytokine 5:38, 1993
9. Carson WE, Ross ME, Baiocchi RA, Marien M, Baioni N, Grabstein K, Caligiuri MA: Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J Clin Invest 96:2578, 1995
10. Matos ME, Schnier GS, Beecher MS, Ashman LK, Williams DE, Caligiuri MA: Expression of a functional c-kit receptor on a subset of natural killer cells. J Exp Med 178:1079, 1993
11. Gong JH, Maki G, Klingemann HG: Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 8:652, 1994
12. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB: Soluble TNF receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151:1548, 1993
13. Ware CF, Crowe PD, Vanarsdale TL, Andrews JL, Grayson MH, Jerzy R, Smith CA, Goodwin RG: Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J Immunol 147:4229, 1991
14. Baiocchi RA, Ross ME, Tan JC, Chou CC, Sullivan L, Haldar S, Monne M, Seiden MV, Narula SK, Sklar J, Croce CM, Caligiuri MA: Lymphomagenesis in the SCID-Human mouse involves abundant production of human interleukin-10. Blood 85:1063, 1995
15. Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, Lai CF, Croce CM, Baumann H, Caligiuri MA: A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest (in press).
16. Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA: The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. Proc Natl Acad Sci USA 91:7553, 1994
17. Nicoletti I, Miglirati G, Pugliacci MD, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
18. Nagata S, Golstein P: The Fas Death Factor. Science 267:1449, 1995
19. Clement MV, Stamenkovic K: Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions. J Exp Med 180:557, 1994
20. Naume B, Gately M, Espevik T: A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. J Immunol 148:2429, 1992
21. Ross ME, Kono Y, Carson WE, Tomasi TB, Caligiuri MA: Transforming growth factor-beta (TGF-β) suppresses γ-IFN production by IL-12 and IL-15 activated natural killer (NK) cells. Proc Am Assoc Cancer Res 36:2795, 1995
22. Bluman EM, Bartynski KF, Avalos BR, Caligiuri MA: Human natural killer cells produce abundant macrophage inflammatory protein-1α in response to monocyte-derived cytokines. J Clin Invest 97:2722, 1996
23. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW: Mice deficient for the 55kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:57, 1993
24. Ortaldo JR, Mason AT, O'Shea JJ: Receptor-induced death in human natural killer cells: Involvement of CD16. J Exp Med 181:339, 1995
25. Azzoni L, Anegon I, Calabretta B, Perussia B: Ligand binding to FcγR induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. J Immunol 154:491, 1995
26. Taga K, Yamauchi A, Kabashima K, Bloom ET, Muller J, Tosato G: Target-induced death by apoptosis in human lymphokine-activated natural killer cells. Blood 87:2411, 1996
27. Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Herrmann SH, Ritz J: Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 175:779, 1992
28. + T lymphocytes, and NK cells. J Immunol 149:3495, 1992
29. Russell JH: Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 7:382, 1995
30. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348, 1995
31. Orange JS, Salazar-Mather TP, Opal SM, Spencer RL, Miller AH, McEwen BS, Biron CA: Mechanism of interleukin 12-mediated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids. J Exp Med 181:901, 1995
32. Fearon DT, Locksley RM: The instructive role of innate immunity in the acquired immune response. Science 272:50, 1996
33. Chomarat P, Rissoan MC, Banchereau J, Miossec P: Interferon gamma inhibits interleukin 10 production by monocytes. J Exp Med 177:523, 1994
34. Carson WE, Lindemann MJ, Baiocchi R, Linett M, Tan JC, Chou CC, Narula S, Caligiuri MA: The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 85:3577, 1995
35. de WallMalefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209, 1991
36. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG: Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965, 1994
37. Mrózek E, Anderson P, Caligiuri MA: Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood 87:2632, 1996
38. Fisher DE: Apoptosis in cancer therapy: Crossing the threshold. Cell 78:539, 1994